Gout (Chronic Refractory) Market Assessment 2024 Featuring 15 Companies and 20 Key Drugs - Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access
30. September 2024 05:35 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Gout (Chronic Refractory) Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has...
U.S. Psoriasis Treatment Awareness & Satisfaction Report: A Review of 2023 - Provides Valuable Insights Into Must-Have Patient-Reported Data Points
26. September 2024 04:17 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Psoriasis in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...
Small Cell Lung Cancer Therapeutics Market Forecast to Reach $10.87 Billion by 2028 Amid Advances in Early Detection and Treatment
19. Februar 2024 04:38 ET
|
Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Small Cell Lung Cancer Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Growth in Small Cell Lung...
Psoriasis Global Market Report 2024: Market to Surge to $39.17 Billion by 2028, Middle East Poised for Rapid Growth - Long-term Forecasts to 2033
26. Januar 2024 03:17 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Psoriasis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The psoriasis market is undergoing significant...
Insights on the Alopecia Treatment Global Market to 2027 - by Condition Type, Medication Type and Geography
06. Januar 2023 08:38 ET
|
Research and Markets
Dublin, Jan. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Alopecia Treatment Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.The global alopecia...
2022 TYSABRI (Natalizumab) Report: A Recombinant Humanized IgG4 Monoclonal Antibody Produced in Murine Myeloma Cells - Drug Insight and Market Forecasts to 2032
22. Dezember 2022 06:03 ET
|
Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "TYSABRI (Natalizumab), Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering."TYSABRI (Natalizumab),...
Global Systemic Lupus Erythematosus (SLE) Market Report 2022-2026: Featuring Pfizer, AstraZeneca, GlaxoSmithKline and Others
29. Juni 2022 06:48 ET
|
Research and Markets
Dublin, June 29, 2022 (GLOBE NEWSWIRE) -- The "Global Systemic Lupus Erythematosus (SLE) Market: Analysis By Product Type, By Route of Administration, By End User, By Region Size and Trends with...
Methotrexate Market Size [2022] | Global Industry Share, Growth Rate, Type & Application, Key Players, Revenue and Gross Margin, Market Drivers, Opportunities, Challenges and Risks Factors Analysis | Market Reports World
23. Mai 2022 05:55 ET
|
Market Reports World
Pune, May 23, 2022 (GLOBE NEWSWIRE) -- The latest global Methotrexate Market research report 2022 provides detailed information about the market overview, modern trends, demand, and recent...
Insights on the Ankylosing Spondylitis Global Market to 2030 - Rise in Number of Hospitals and Diagnostic Centers is Driving Growth
05. Mai 2022 08:08 ET
|
Research and Markets
Dublin, May 05, 2022 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis Market by Drug Class and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been...